Business
Identiv Wins 2021 Security Today IoT New Product of the Year Award
uTrust Sense SyringeCheck honored as Internet of Things winner for delivering smarter, simpler, safer medical outcomes FREMONT, Calif., Aug. 19, 2021

About this update from Identiv, Inc.
[{"type":"text","content":"uTrust Sense SyringeCheck honored as Internet of Things winner for delivering smarter, simpler, safer medical outcomes\n\n\nFREMONT, Calif., Aug. 19, 2021 /PRNewswire/ -- Identiv, Inc. (NASDAQ: INVE), a global leader in digital identification and security, today announced its near field communication (NFC)-enabled injectable dose monitoring device won the 2021 Security Today New Product of the Year Award in the Internet of Things (IoT) category. The annual award program honors the outstanding technological achievements of innovators with products considered valuable in their ability to propel positive business and security outcomes. \n\n \n \n \n \n \n \n\n \nIdentiv's uTrust Sense SyringeCheck honored as IoT winner for delivering smarter, simpler, safer medical outcomes.Security Today selected Identiv's uTrust Sense SyringeCheck as the winning IoT entry for its ability to help patients take medication correctly. It is the only intelligent injectable technology available today and allows clinical trials to achieve meaningful results and supports insurance companies' prescription programs. It also makes the lives of those receiving and using medication easier and more affordable by permitting in-home injections instead of requiring expensive and time consuming in-clinic visits. \nThe NFC-enabled syringe dose monitoring device features a front-end capacitive sensor to measure fill levels combined with a companion app and alarm function to guide patients through the correct medication protocol, greatly simplifying the process of complex prescription programs. The solution is highly intuitive thanks to its tap-and-go sensor read-out and is seamlessly compatible with telemedicine and at-home compliance monitoring. \nIn addition to ensuring patient safety, healthcare providers can leverage uTrust Sense SyringeCheck to conduct trials in the home environment instead of a clinic — a critical benefit with the surge of COVID-19 variants — making the solution lower cost and more convenient. Providers can quickly identify non-compliant participants, exclude them from results, and save money with more efficient studies.\n\"With the continued, exponential growth of connected devices, there is increased demand for new ways to leverage RFID and NFC in MedTech, helping healthcare providers and patients ensure the safe and secure delivery of medic...